IB Acquisition Corp. Unit
IBACU
NASDAQ10.05
USD
-0.01
- -
ISIN
US44934N2071
CUSIP
44934N207
Return %
Stock
S&P500
1Y
100,499,900.00
26.53
3Y
100,499,900.00
76.60
5Y
100,499,900.00
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Adelmo S. Lopez
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- Similar Companies
- Business
- IB Acquisition Corp. Unit is a special purpose acquisition company (SPAC) formed to identify, acquire, and operate a target company through a business combination. Founded recently, the company operates primarily within the investment sector, targeting high-growth businesses across a variety of industries including fintech, healthcare and life sciences, sports and entertainment, and consumer goods. The company conducts its investment and acquisition activities broadly without limiting to a specific geographic region, aiming for opportunities in the US and globally. IB Acquisition Corp. Unit's core business activity involves raising capital through its initial public offering (IPO) and utilizing these funds to complete mergers, acquisitions, or business combinations with promising companies in its focus sectors. The units comprise shares and warrants for acquisition purposes, with the company’s stock listed on the Nasdaq Global Market under the ticker IBACU. The company closed its IPO in March 2024, raising around $100 million in capital. IB Acquisition Corp. Unit engages in providing investment capital and strategic support to the businesses it acquires, supporting growth and operational expansion. In the last 1-2 years, IB Acquisition Corp. Unit has approved an extension to its deadline for completing an initial business combination from September 28, 2025, to March 28, 2026. This extension provides the company additional time to identify and consummate a business combination, reflecting ongoing strategic deliberations and market conditions. The company has not disclosed any completed acquisitions or partnerships as of the latest filings but continues to focus on its broad industry sectors for potential deals. The board and executive management team include Adelmo “Al” Lopez as Chairman and CEO, Christy Albeck as CFO, and John Joyce as Vice Chairman. IB Acquisition Corp. Unit's business model and operational focus center on leveraging its capital markets presence to execute mergers or acquisitions that create value for shareholders by investing in innovative and growth-oriented companies. The company operates under the regulatory framework applicable to publicly traded SPACs and maintains its corporate headquarters in the United States. It continues to hold its funds in trust accounts until a successful business combination or liquidation event, adhering to SPAC regulatory and shareholder approval requirements. Overall, IB Acquisition Corp. Unit functions as a financial vehicle facilitating access to public capital markets for target companies in fintech, healthcare, life sciences, consumer goods, and entertainment sectors, with ongoing efforts to secure a transformative business combination within its extended timeline. The company's recent IPO, extension of business combination deadline, and diversified sector focus constitute its latest major corporate developments.
GNQ Insilico Inc. to go Public Through Business Combination With IB Acquisition Corp. (NASDAQ: IBAC)
IB Acquisition Corp. Announces Upcoming Automatic Unit Separation
U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week
IB Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering, Including Full Exercise of Underwriter Over-Allotment Option